Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Net Cash Flow (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Net Cash Flow for 3 consecutive years, with $65.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 1332.08% to $65.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $128.7 million through Dec 2025, up 1843.53% year-over-year, with the annual reading at $128.7 million for FY2025, 1843.53% up from the prior year.
  • Net Cash Flow for Q4 2025 was $65.4 million at Nuvation Bio, up from -$149.0 million in the prior quarter.
  • The five-year high for Net Cash Flow was $200.1 million in Q2 2025, with the low at -$149.0 million in Q3 2025.
  • Average Net Cash Flow over 3 years is $5.2 million, with a median of $2.1 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 66146.53% in 2025, while the deepest fall reached 4149.07% in 2025.
  • Over 3 years, Net Cash Flow stood at $18.3 million in 2023, then crashed by 74.96% to $4.6 million in 2024, then soared by 1332.08% to $65.4 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $65.4 million, -$149.0 million, and $200.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.